SAN CARLOS, Calif.--(BUSINESS WIRE)--Natus Medical Incorporated (Nasdaq:BABY) today announced that it has resumed all production and shipping operations at its Olympic Medical manufacturing facility in Seattle, Washington. On October 15, 2007, Natus received a warning letter from the Food & Drug Administration (“FDA”) related to the Olympic facility. The FDA letter focused on process deficiencies that were identified during an FDA inspection in April 2007. On November 1, 2007, the Company voluntarily shut down operations at the facility in order to adequately address the findings identified by the FDA. In a letter to the FDA dated November 27, 2007, Natus fully responded to the issues raised in the warning letter.
